To include your compound in the COVID-19 Resource Center, submit it here.

Linagliptin: Phase III data

A double-blind, international Phase III trial in 1,519 Type II diabetics inadequately controlled with metformin showed that once-daily 5 mg linagliptin plus metformin was

Read the full 241 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE